Stock screener

RIGL

Conviction 58HealthcareScan · Thu, Jun 25, 2026
RIGL$36.98+1.18%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 368.08K
Mar 26Apr 14May 1May 19Jun 8Jun 25
RIGEL PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.rigel.com ↗
Price36.98
Change+1.18%
Gap+0.93%
Rel volume1.02×
Avg volume361.31K
Avg $ vol11.69M
SMA 2032.23
SMA 5030.67
SMA 20033.98
Price vs 50+20.58%
Price vs 200+8.84%
MA stackmixed
50/200 cross—
Supertrendup · 32.06
RSI (14)75
MACD hist0.55
MACD cross—
Stoch %K / %D96 / 92
ADX (14)21
+DI / −DI29 / 12
RSI divergence—
MACD divergence—
ATR %+4.20%
ADR %4.38%
52w high50.96
52w low18.42
From 52w high-27.43%
Above 52w low+100.76%
New 52w highNo
SqueezeOff
Bollinger width28.89%
%B1.01
Donchian pos96.38%
Donchian high37.30
Donchian low28.46
AVWAP (52w high)34.87
vs AVWAP high+6.07%
AVWAP (52w low)34.42
vs AVWAP low+7.43%
OBV trendUp
Chaikin MF (20)0.01
Today vs 20d1.02×
Avg vol (14d)368.07K
Avg vol (20d)361.31K
Avg $ vol (20d)11.69M
Market cap684.21M
RS 3m (vs SPY)+27.62%
RS 6m (vs SPY)-19.85%
RS line new highYes
Trend template5/8
Technical rank64.5
1 week+10.82%
1 month+26.77%
3 months+40.66%
6 months-16.26%
1 year+97.75%
YTD-11.59%
P/E1.86
P/B1.71
P/S2.33
P/FCF9.10
EPS19.48
Div yield—
ROE91.78%
ROA72.73%
Debt/Eq0.11
Current2.62
EV/EBITDA5.51
Gross margin5.92%
Net margin124.72%
Rev growth64.15%
EPS growth1999.08%
Price target59.33
Target upside60.44%
Analyst ratingBuy
Institutional92.91%
Ent. value704.8M
Revenue58.82M
Net income8.65M
Gross profit—
Free cash flow75.2M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out18.5M
Employees174
ListedWed, Nov 29, 2000
Free float16.56M
Float %89.5%
Short interest3.93M
Days to cover12.0d
Short volume58.2%
Squeeze score77 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast$0.91 · 2 est
Last EPS vs est$0.44 vs $0.74
Last surprise-40.5% miss
Setup gradeC
Conviction58 / 100
Pattern quality—
Tech rank64.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance32.08
Support25.61
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RIGL

All disclosures →
No recent disclosed trades by Congress in RIGL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RIGL · 7 buys · 3 sells

InsiderSideShares
Ali-Jackson Kamil
Director · Common Stock · 2026-06-22
Sell2.5K
Schorno Dean L
EVP & Chief Financial Officer · Employee Stock Option (right to buy) · 2026-06-17
Grant7.39K
Furey Raymond J.
EVP, GC, CCO & Corp Sec · Employee Stock Option (right to buy) · 2026-06-17
Grant7.39K
Santos David A
EVP, Chief Commercial Officer · Employee Stock Option (right to buy) · 2026-06-17
Grant7.39K
RODRIGUEZ RAUL R
CEO, President · Employee Stock Option (right to buy) · 2026-06-17
Grant31.7K
Rojkjaer Lisa
EVP, Chief Medical Officer · Employee Stock Option (right to buy) · 2026-06-17
Grant9.38K
Rojkjaer Lisa
EVP, Chief Medical Officer · Employee Stock Option (right to buy) · 2026-06-17
Grant7.39K
RODRIGUEZ RAUL R
CEO, President · Common Stock · 2026-06-01
Tax2.42K
Schorno Dean L
EVP & Chief Financial Officer · Common Stock · 2026-06-01
Exercise1.2K
Rojkjaer Lisa
EVP, Chief Medical Officer · Common Stock · 2026-06-01
Tax850

SEC filings

EDGAR filings in RIGL · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.